corrigenda
2007; Wiley; Volume: 100; Issue: 3 Linguagem: Português
10.1111/j.1464-410x.2007.07160_1.x
ISSN1464-410X
Tópico(s)Bladder and Urothelial Cancer Treatments
ResumoBJU InternationalVolume 100, Issue 3 p. 718-719 Free Access corrigenda This article corrects the following: A review of targeted screening for prostate cancer: introducing the IMPACT Study Anita V. Mitra, Elizabeth K. Bancroft, Rosalind A. Eeles, , Volume 99Issue 6BJU International pages: 1350-1355 First Published online: April 5, 2007 First published: 31 July 2007 https://doi.org/10.1111/j.1464-410X.2007.07160_1.xAboutSectionsPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat In [1], the following error was present in the submitted manuscript and subsequently appeared Online Early and in the print issue BJU99:6. PAGES 1353–1355 REFERENCE 1 Mitra AV, Bancroft EK, Eeles RA, on behalf of the IMPACT Steering Committee and Collaborators. A review of targeted screening for prostate cancer: introducing the IMPACT Study. BJU Int 2007; 99: 1350– 5Wiley Online LibraryCASPubMedWeb of Science®Google Scholar ACKNOWLEDGEMENTS AND APPENDIX In the Acknowledgements and Appendix, a number of people were missing in the published article; the original Acknowledgements and Appendix as supplied were incomplete. The correct and complete list is printed below: ACKNOWLEDGEMENTS We thank the Carrier Clinic Collaborators at the Royal Marsden NHS Foundation Trust, London; Dr Huw Dorkins and his team at the Kennedy Galton Centre, London; Drs Louise Izatt and Gabi Pichert and their team at Guy’s Hospital, London; Professor Shirley Hodgson and her team at St George’s Hospital; Dr Lucy Side and her team at Churchill Hospital, Oxford; Prof Gareth Evans and his team at St. Mary’s Hospital, Manchester; Prof Diana Eccles and her team at The Princess Anne Hospital, Southampton; Drs Joan Paterson and Virginia Clowes at Addenbrooke’s Hospital, Cambridge for their help with recruitment and S. and A. Cliff and the Ronald and Rita McAulay Foundation for funding support. In addition, Dr Sharifi for his input into writing the protocol. THE IMPACT STEERING COMMITTEE Mrs Audrey Ardern-Jones Senior Clinical Nurse Specialist and Genetic Counsellor, Sutton, UK, Professors Chris Bangma, and Fritz H Schröder, Professors of Urology, Rotterdam, the Netherlands, Prof David Dearnaley, Head of Urology, Sutton, UK, Prof Douglas Easton, Director, CRC Genetic Epidemiology Unit, Strangeways Research Laboratories, Cambridge, Prof Diana Eccles, Consultant in Clinical Genetics, Southampton, UK, Prof Gareth Evans, Consultant in Clinical in Genetics, Manchester, UK, Dr Alison Falconer, Consultant in Clinical Oncology, London, UK, Prof Christopher Foster, Consultant in Histopathology, Liverpool, UK, Prof Henrik Grönberg, Department of Radiosciences/Oncology, Umea, Sweden, Prof Freddie Hamdy, Prof of Urology, Sheffield, UK, Dr Óskar Jóhannsson, Department of Clinical Oncology, Reykjavik, Iceland, Dr Vincent Khoo, Consultant Clinical Oncologist, London, UK, Dr Zsofia Kote-Jarai, Staff Scientist, Sutton, UK, Prof Hans Lilja, Attending Research Clinical Chemist, MSKCC, New York, USA, Dr Mohnish Suri, Consultant Clinical Geneticist, Nottingham, Dr Penny Wilson, Consultant to the Biotechnology and Healthcare Industries Cheshire, Dr Paul Sibley, EURO/DPC, Gwynedd, Dr Susan Peock, EMBRACE Study Co-ordinator, Cambridge, Dr Gad Rennert, Dept of Community Medicine and Epidemiology CHS National Cancer Control Center, Israel. IMPACT COLLABORATORS Dr Gillian Mitchell, Director of the Familial Cancer Centre & Consultant Clinical Oncologist, Melbourne, Australia, Dr Mary-Anne Young, Dr Georgia Chenevix-Trench, Principal Research Fellow, Queensland Institute of Medical Research, Brisbane, Dr Geoffrey Lindeman, Head of Family Cancer Centre, Melbourne, Australia, Dr Graeme Suthers and Ms Meryl Altree, Research Nurse, Clinical Genetics Service, Adelaide, Australia, Dr Alan Stapleton and Dr Louise Taylor, Department of Urology, Adelaide, Australia, Prof Georg Bartsch, Head of Urology, Innsbruck, Austria, Prof Teresa Wagner, Ms Christine Furhauser and Dr Verena Korn Department of Obstetrics and Gynecology, Wein, Austria, Dr Kyriakos Kyriakou, Cell Biologist, Nicosia, Cyprus, Dr Anne-Marie Gerdes, Clinical Genetics Department, Odense, Denmark, Prof Laurent Boccon-Gibod Clinique Urologique, Paris, France, Dr Catherine Nogues, Dr Nadine Andrieu, Saint-Cloud, France, Dr Jenny Chang-Claude Division of Epidemiology, Heidelberg, Germany, Prof Dr Rita Schmutzler and Dr Kerstin Luedtke-Heckenkamp, Köln, Germany, Dr Drakoulis Yannoukakos and Dr Theodore Anagnostopoulos, Molecular Diagnostics Laboratory, Athens, Greece, Prof E Olah and Dr Janos Papp, Department of Molecular Genetics, Budapest, Hungary, Prof Jorunn Eyfjord, Head of Molecular Genetics, Reykjavik, Iceland, Prof T Rajkumar, Head of Molecular Oncology, Adyar Chennai, India, Dr Asher Salmon, Institute of Oncology, Jerusalem, Israel, Dr Maria Caligo and Prof G. Bevilacqua, Section of Genetic Oncology, Pisa, Italy, Dr P Radice, Dr N Nicolai and Dr Riccardo Valdagni, Section of Genetic Oncology, Milan, Italy, Prof Janis Gardovskis, Dr Arvids Irmejs and Dr Andris Abele, Riga, Latvia, Dr M. Nansalmaa, Ulaanbaatar, Mongolia, Dr Lovise Maehle, Dr Wolfgang Lilleby, Dr Ketil Heimdahl and Dr Pal Moller, Departments of Genetics and Oncology, Olso, Norway, Prof Fernando Regateiro and Prof C De Silva, Coimbra, Portugal, Dr Ludmila Lyubchenko, Clinical Genetics Laboratory & Out-Patient Department, Russia, Prof J Benitez, Dr Ana Osorio, Department of Human Genetics, Madrid, Spain, Dr Pedro P. Segura, and Dr Trinidad Caldes, Molecular Oncology Laboratory, Madrid, Spain, Dr Ignacio Blanco, Dr Merce Peris, Genetic Counselling Unit, Barcelona, Spain, Prof Hakan Olsson and Dr Niklas Loman, Department of Oncology, Lund, Sweden, Prof Ola Bratt, Consultant Urological Surgeon, Lund, Sweden, Dr Brita Arver, Department of Clinical Genetics, Stockholm, Sweden, Dr C.J. van Asperen, Department of Clinical Genetics, Leiden, the Netherlands, Prof Bart Kiemeny, Departments of Epidemiology and Urology, Nijmegen, the Netherlands, Dr Hans Vasen, Dr Matti Rookus, Dr Fernando van Leeuwen and Dr Richard Brohet, Department of Epidemiology, Amsterdam, the Netherlands, Prof G Luleci and Dr Esra Manguoglu, Departments Medical Biology and Genetics, Antalya, Turkey, Dr Ugur Ozbek, Prof of Genetics, Istanbul, Turkey, Dr Carole Brewer, Consultant Clinical Geneticist, Exeter, Prof Cyril Chapman and Dr Trevor Cole, Consultants in Clinical Genetics, Birmingham, Dr Jackie Cook, Consultant in Clinical Genetics, Sheffield, Mrs Margaret Cook, Cancer Research UK Genetic Epidemiology Unit, Cambridge, Prof Colin Cooper, Molecular Carcinogenesis, Sutton, Dr Rosemarie Davidson, Consultant in Clinical Genetics, Glasgow, Dr Alan Donaldson, Consultant Clinical Geneticist, Bristol, Dr Huw Dorkins/ Mrs Carole Cummings, Middlesex, Dr Fiona Douglas, Consultant Clinical Geneticist, Newcastle, Prof Neva Haites/Dr Helen Gregory, Prof in Medical Genetics/Staff Grade Medical Genetics, Aberdeen, Prof Shirley Hodgson, Consultant Clinical Geneticist, London, Dr Louise Izatt, Lead Consultant in Cancer Genetics, London, Dr James Mackay and Dr Mark Tischkowitz, Clinical Geneticist, London, Dr Joan Paterson and Dr Virginia Clowes, Clinical Geneticist, Cambridge, Dr Lucy Side, Consultant in Clinical Genetics, Oxford, Prof Mike Stratton, The Wellcome Trust Sangar Institute, Cambridge, Mr Alan Thompson, Consultant Urologist, London, UK, Dr David Goldgar, Genetic Epidemiology, Utah, USA, Professor Cyril Fisher, Consultant Histopathologist, London, UK. Volume100, Issue3September 2007Pages 718-719 ReferencesRelatedInformation
Referência(s)